The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...

Clinical Care Options in collaboration with the National Eczema Association is hosting an innovative and engaging symposium IL-13 Inhibition in Moderate to Severe Atopic Dermatitis: A Clinical Skills ...

Treating eczema starts with a solid skincare routine, but you may need more than just moisturizer to get you through a ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic ...

The best out-of-the-box tricks to treat atopic dermatitis (eczema), according to expert dermatologists, plus products to try.

Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...

When people classically think of eczema, they’re usually referring to atopic dermatitis, a chronic skin condition that’s driven by inflammation. However, eczema could also point to a number of ...